Xiangcheng Tang

500 citations
25 papers · 309 indexed · h-index 11
Topics
interferon and immune responses (5 papers)Retinal Diseases and Treatments (3 papers)Ubiquitin and proteasome pathways (3 papers)

In The Last Decade

Xiangcheng Tang

23 papers receiving 305 citations

Peers

Xiangcheng Tang
Comparison fields: 5 of 79
  • Molecular Biology 185
  • Immunology 77
  • Ophthalmology 48
  • Cell Biology 40
  • Epidemiology 27
Replace Álvaro Viedma-Poyatos with:
Álvaro Viedma-Poyatos Spain
Vipul M. Parmar United States
Dee Shen United States
Eszter Dombi United Kingdom
Julia M. D. Grandjean United States
Jiaoyue Hu China
Marc Kästle Germany
Mathieu Nivon France
Kuangqi Chen China
Yizhi Lin United States
Xiangcheng Tang relative to Álvaro Viedma-Poyatos Spain Álvaro Viedma-Poyatos's profile →
Citations per field
00.5×1.5×1.8×
Álvaro Viedma-Poyatos · 1×
Citations per year

Countries citing papers authored by Xiangcheng Tang

Since Specialization
Citations

This map shows the geographic impact of Xiangcheng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangcheng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangcheng Tang more than expected).

Fields of papers citing papers by Xiangcheng Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangcheng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangcheng Tang. The network helps show where Xiangcheng Tang may publish in the future.

Co-authorship network of co-authors of Xiangcheng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangcheng Tang. A scholar is included among the top collaborators of Xiangcheng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangcheng Tang. Xiangcheng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 1
4 16
5 1
6 76
7 5
8 24
9 11
10 2
11 5
12 19
13 3
14 1
15 6
16 24
17 10
18 13
19 17
20 8

About Xiangcheng Tang

Xiangcheng Tang is a scholar working on Aging, Physiology and Ophthalmology, having authored 25 papers that have together received 309 indexed citations. Recurring topics across this work include interferon and immune responses (5 papers), Retinal Diseases and Treatments (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Aging (10 citations), Ophthalmology (48 citations) and Immunology (77 citations). Xiangcheng Tang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lili Gong, David Wan‐Cheng Li, Ming Zou, Guy M. Benian, Ruili Qi, Timothy C. Chambers, Jan Pohl, Jun Lei, Qin Ke and Yizhi Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Free Radical Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026